N@N

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ:CORT), Up By 16.54% ($0.61) After BUYINS.NET SqueezeTrigger Report Released on Tuesda

^{Published on 2012-06-08 09:40:38 - WOPRAI}
 

June 8, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, released a report on Tuesday, May 8th 2012 at 13:15:00 PDT stating that CORCEPT THERAPEUTICS INCORPORATED (NASDAQ:CORT) was expected to be Up After it crossed above its SqueezeTrigger Price of 3.68 on Tuesday, May 8th 2012. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=cort&id=272596

From August 2009 to May 2012, an aggregate amount of 41119017 shares of CORT have been shorted for a total dollar value of $123357051. The CORT SqueezeTrigger price of $3.68 is the volume weighted average price that all shorts are short in shares of CORT. There is still approximately $13,104,290 of potential short covering in shares of CORT.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com .

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ:CORT) - Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders. The company focuses on the development of drugs for disorders that are associated irregular levels of the steroid hormone called cortisol. Its lead product includes CORLUX, a glucocorticoid receptor II (GR-II) antagonist, which is in Phase III clinical trials for the treatment of Cushing's Syndrome and for psychotic depression. The company is also developing next-generation selective GR-II receptor antagonists for the treatment of various psychiatric and metabolic disorders. In addition, Corcept Therapeutics is developing CORT 108297, a lead compound from its selective GR-II antagonists for the prevention of weight gain induced by antipsychotic medication, which is in Phase I clinical trial. It has a patent license from Stanford University for the use of GR-II antagonists, as well as has agreements with ICON Clinical Research, LP; and MedAvante, Inc. The company was founded in 1998 and is headquartered in Menlo Park, California.

The SqueezeTrigger database of approximately 1 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net